Senator, we did not value that asset, you know, per se, as part of the bankruptcy. However, the bidders are looking at that and placing a value on it. A bidder wanting to buy your company is assessing whether or not they can buy that data as part of how much they're going to pay you. Yes. And the more customers that delete their information, the less of that asset is available to transfer, is what you're telling. (02:52–03:02)
CLAIM
Asserts that bidders are evaluating the purchase of genetic data as part of the company's value.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
